Can herpes zoster (shingles) cause encephalopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, shingles (herpes zoster) can cause encephalopathy, which is a brain dysfunction that can manifest as altered mental status, confusion, or cognitive impairment. Shingles is caused by the varicella-zoster virus (VZV), which can spread to the central nervous system in some cases, as noted in studies such as 1. This neurological complication is more common in immunocompromised individuals, such as those with HIV/AIDS, cancer patients on chemotherapy, or organ transplant recipients on immunosuppressive medications. The virus can directly infect brain tissue or trigger an inflammatory response that affects brain function.

Key Considerations

  • The presentation of encephalitis caused by VZV can be acute or sub-acute with fever, headache, altered consciousness, ataxia, and seizures, as described in 1.
  • Reactivation of VZV may also lead to encephalitis, especially in the elderly or the immunocompromised, with an insidious onset and sometimes no zoster rash, fever, or CSF pleocytosis, as noted in 1.
  • Treatment typically involves high-dose intravenous antiviral medications like acyclovir (10-15 mg/kg every 8 hours for 14-21 days), valacyclovir, or famciclovir, along with supportive care, as recommended in 1 and 1.
  • Early diagnosis and treatment are crucial to prevent long-term neurological damage, with the dosage of acyclovir in patients with normal renal function being 10 mg/kg intravenously every 8 h for 14–21 days, as specified in 1.

Important Recommendations

  • Patients with shingles who develop headache, confusion, seizures, or behavioral changes should seek immediate medical attention, as these may be signs of encephalopathy or other neurological complications.
  • Acyclovir should be initiated in all patients with suspected encephalitis as soon as possible, pending results of diagnostic studies, as advised in 1.
  • The use of adjunctive corticosteroids may be considered in some cases, although the evidence is not yet conclusive, as discussed in 1 and 1.

From the Research

Herpes Zoster and Encephalopathy

  • Herpes zoster, also known as shingles, can cause encephalopathy, as evidenced by several studies 2, 3.
  • Encephalopathy is a condition characterized by brain disease, damage, or malfunction, and can present with symptoms such as altered mental status, confusion, and disorientation.
  • Herpes zoster-associated encephalitis (HZAE) is a rare but serious complication of herpes zoster, and can occur in both immunosuppressed and non-immunosuppressed individuals 3.

Clinical Findings and Treatment

  • The clinical findings of HZAE include disturbances of mental function, ataxia, and nuchal rigidity, as well as abnormal spinal fluid findings and EEG results 3.
  • Treatment with acyclovir has been shown to have a beneficial effect in patients with HZAE, with rapid resolution of symptoms and normalization of EEG results 2.
  • However, acyclovir can also cause neurotoxicity, particularly in patients with renal impairment or those who are immunocompromised, which can present with symptoms similar to HZAE 4, 5.

Key Considerations

  • Differentiating between HZAE and acyclovir neurotoxicity is crucial, as the management of these conditions is vastly different 5.
  • Patients with herpes zoster should be closely monitored for signs of encephalopathy, and treatment with acyclovir should be initiated promptly if HZAE is suspected 3.
  • The use of valacyclovir and acyclovir in patients with renal impairment or those who are immunocompromised should be done with caution, due to the risk of neurotoxicity 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Herpes zoster associated encephalitis: clinical findings and acyclovir treatment.

Scandinavian journal of infectious diseases, 1988

Research

Acyclovir-induced neurotoxicity in an immunocompromised patient.

SAGE open medical case reports, 2020

Research

Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.

American journal of therapeutics, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.